Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Landos Biopharma stock

Learn how to easily invest in Landos Biopharma stock.

Landos Biopharma is a biotechnology business based in the US. Landos Biopharma shares (LABP) are listed on the NASDAQ and all prices are listed in US Dollars. Landos Biopharma employs 46 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Landos Biopharma stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – LABP. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Trade stocks and ETFs for $0 and no annual fee
  • Minimum deposit of $10 required
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Landos Biopharma stock price (NASDAQ: LABP)

Use our graph to track the performance of LABP stocks over time.

Landos Biopharma shares at a glance

Information last updated 2023-01-26.
Latest market close$0.42
52-week range$0.21 - $3.67
50-day moving average $0.35
200-day moving average $0.68
Wall St. target price$2.70
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.06

Buy Landos Biopharma stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Landos Biopharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Landos Biopharma price performance over time

Historical closes compared with the close of $0.4211 from 2023-01-31

1 week (2023-01-25) 0.74%
1 month (2022-12-30) -15.78%
3 months (2022-11-02) 26.84%
6 months (2022-08-02) -46.90%
1 year (2022-02-02) -86.19%
2 years (2021-01-29) N/A
3 years (2020-01-29) N/A
5 years (2018-01-29) N/A

Landos Biopharma financials

Gross profit TTM $18 million
Return on assets TTM -43.78%
Return on equity TTM -78.5%
Profit margin 0%
Book value $1.09
Market capitalisation $17.5 million

TTM: trailing 12 months

Landos Biopharma share dividends

We're not expecting Landos Biopharma to pay a dividend over the next 12 months.

Landos Biopharma overview

Landos Biopharma, Inc. , a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and eosinophilic esophagitis; NX-13, a gut-restricted oral therapeutic that targets NOD-like receptor X1 (NOD-like), a mitochondria-associated receptor associated with the modulation of inflammatory cytokines for UC and CD; and LABP-104, an orally-active and systemically bioavailable small molecule therapeutic candidate that targets LANCL2 agonist for the treatment of systemic lupus erythematosus and rheumatoid arthritis (RA). Its preclinical candidates in development include LABP-66 is an oral and small molecule NOD-like pathway agonist for the treatment of multiple sclerosis and Alzheimer's disease; LABP-69, an oral PLXDC2 agonist for the treatment of diabetic nephropathy and RA; LABP-73, an oral and small molecule NLRX1 pathway agonist in development for the treatment of asthma and chronic obstructive pulmonary disease; and LABP-111, an oral and small molecule LANCL2 pathway agonist for the treatment of nonalcoholic steatohepatitis and type 1 diabetes. The company was incorporated in 2017 and is headquartered in Blacksburg, Virginia. .

Frequently asked questions

What percentage of Landos Biopharma is owned by insiders or institutions?
Currently 24.478% of Landos Biopharma shares are held by insiders and 48.333% by institutions.
How many people work for Landos Biopharma?
Latest data suggests 46 work at Landos Biopharma.
When does the fiscal year end for Landos Biopharma?
Landos Biopharma's fiscal year ends in December.
Where is Landos Biopharma based?
Landos Biopharma's address is: 1800 Kraft Drive, Blacksburg, VA, United States, 24060
What is Landos Biopharma's ISIN number?
Landos Biopharma's international securities identification number is: US5150691021

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site